A stepwise activation model for the insulin receptor

참고문헌 (105)

1. Haeusler, R. A., "Biochemical and cellular properties of insulin receptor signalling", Nat. Rev. Mol. Cell Biol, 19, pp.31~44 (2018)
2. Belfiore, A., "Insulin receptor isoforms in physiology and disease : an updated view", Endocr. Rev, 38, pp.379~431 (2017)
3. Cai, W., "Domain-dependent effects of insulin and IGF-1 receptors on signalling and gene expression", Nat. Commun, 8, pp.14892~ (2017)
4. Worster, D. T., "Akt and ERK control the proliferative response of mammary epithelial cells to the growth factors IGF-1 and EGF through the cell cycle inhibitor p57Kip2", Sci. Signal, 5, pp.ra19~ (2012)
5. "Diagnosis and classification of diabetes mellitus", Diabetes Care, 37, pp.S81~S90 (2014)
6. Artunc, F., "The impact of insulin resistance on the kidney and vasculature", Nat. Rev. Nephrol, 12, pp.721~737 (2016)
7. Ormazabal, V., "Association between insulin resistance and the development of cardiovascular disease", Cardiovasc. Diabetol, 17, pp.122~ (2018)
8. Gallagher, E. J., "Hyperinsulinaemia in cancer", Nat. Rev. Cancer, 20, pp.629~644 (2020)
9. Kim, J., "Functional selectivity of insulin receptor revealed by aptamertrapped receptor structures", Nat. Commun, 13, pp.6500~ (2022)
10. Weis, F., "The signalling conformation of the insulin receptor ectodomain", Nat. Commun, 9, pp.4420~ (2018)
11. Scapin, G., "Structure of the insulin receptor-insulin complex by singleparticle cryo-EM analysis", Nature, 556, pp.122~125 (2018)
12. Uchikawa, E., "Activation mechanism of the insulin receptor revealed by cryo-EM structure of the fully liganded receptorligand complex", Elife, 8, pp.e48630~ (2019)
13. Gutmann, T., "Cryo-EM structure of the complete and ligand-saturated insulin receptor ectodomain", J. Cell Biol, 219, pp.e201907210~ (2020)
14. Kirk, N. S., "Activation of the human insulin receptor by non-insulin-related peptides", Nat. Commun, 13, pp.5695~ (2022)
15. Li, J., "Synergistic activation of the insulin receptor via two distinct sites", Nat. Struct. Mol. Biol, 29, pp.357~368 (2022)
16. Nielsen, J., "Structural investigations of full-length insulin receptor dynamics and signalling", J. Mol. Biol, 434, pp.167458~ (2022)
17. Park, J., "Activation of the insulin receptor by an insulin mimetic peptide", Nat. Commun, 13, pp.5594~ (2022)
18. Wu, M., "Functionally selective signaling and broad metabolic benefits by novel insulin receptor partial agonists", Nat. Commun, 13, pp.942~ (2022)
19. Xiong, X., "Symmetric and asymmetric receptor conformation continuum induced by a new insulin", Nat. Chem. Biol, 18, pp.511~519 (2022)
20. "Structural conservation of insulin/IGF signalling axis at the insulin receptors level in drosophila and humans" (2023)[URL]
21. Menting, J. G., "How insulin engages its primary binding site on the insulin receptor", Nature, 493, pp.241~245 (2013)
22. Yunn, N. -O., "Agonistic aptamer to the insulin receptor leads to biased signaling and functional selectivity through allosteric modulation", Nucleic Acids Res, 43, pp.7688~7701 (2015)
23. Yunn Na-Oh, "An aptamer agonist of the insulin receptor acts as a positive or negative allosteric modulator, depending on its concentration", Experimental and Molecular Medicine, 54, pp.1~11 (2022), 생화학분자생물학회[DOI]
24. Jensen, M., "Activation of the insulin receptor by insulin and a synthetic peptide leads to divergent metabolic and mitogenic signaling and responses", J. Biol. Chem, 282, pp.35179~35186 (2007)
25. Bhaskar, V., "A fully human, allosteric monoclonal antibody that activates the insulin receptor and improves glycemic control", Diabetes, 61, pp.1263~1271 (2012)
26. Lawrence, M. C., "Understanding insulin and its receptor from their threedimensional structures", Mol. Metab., 52, pp.101255~ (2021)
27. Choi, E., "The activation mechanism of the insulin receptor : a structural perspective", Annu Rev. Biochem, 92, pp.247~272 (2023)
28. Lemmon, M. A., "Cell signaling by receptor tyrosine kinases", Cell, 141, pp.1117~1134 (2010)
29. White, M. F., "Insulin action at a molecular level – 100 years of progress", Mol. Metab, 52, pp.101304~ (2021)
30. Youngren, J. F., "Regulation of insulin receptor function", Cell Mol. Life Sci, 64, pp.873~891 (2007)
31. Dickens, M., "Analysis of the order of autophosphorylation of human insulin receptor tyrosines 1158, 1162 and 1163", Biochem. Biophys. Res. Commun, 186, pp.244~250 (1992)
32. Wei, L., "Expression, characterization, and crystallization of the catalytic core of the human insulin receptor proteintyrosine kinase domain", J. Biol. Chem, 270, pp.8122~8130 (1995)
33. Hubbard, S. R., "Crystal structure of the tyrosine kinase domain of the human insulin receptor", Nature, 372, pp.746~754 (1994)
34. Hubbard, S. R., "Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog", EMBO J, 16, pp.5572~5581 (1997)
35. Issad, T., "Analysis of insulin receptor phosphorylation sites in intact rat liver cells by two-dimensional phosphopeptide mapping. Predominance of the tris-phosphorylated form of the kinase domain after stimulation by insulin", Biochem. J, 275, pp.15~21 (1991)
36. Kohanski, R. A., "Insulin receptor autophosphorylation. II. Determination of autophosphorylation sites by chemical sequence analysis and identification of the juxtamembrane sites", Biochemistry, 32, pp.5773~5780 (1993)
37. Liao, Z., "Comprehensive insulin receptor phosphorylation dynamics profiled by mass spectrometry", Febs j, ~ (2021)
38. Gustafson, T. A., "Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1with the NPEY motif of the insulin receptor via a novel non-SH2 domain", Mol. Cell Biol, 15, pp.2500~2508 (1995)
39. Eck, M. J., "Structure of the IRS-1 PTB domain bound to the juxtamembrane region of the insulin receptor", Cell, 85, pp.695~705 (1996)
40. Pillay, T. S., "Insulin stimulates the tyrosine dephosphorylation of pp125 focal adhesion kinase", J. Biol. Chem, 270, pp.991~994 (1995)
41. Tennagels, N., "Autophosphorylation of the two C-terminal tyrosine residues Tyr1316 and Tyr1322 modulates the activity of the insulin receptor kinase in vitro", FEBS Lett, 479, pp.67~71 (2000)
42. Paz, K., "Interaction between the insulin receptor and its downstream effectors. Use of individually expressed receptor domains for structure", function analysis, 1996, pp.271, 6998~7003
43. Huang, X., "The PI3K", AKT pathway in obesity and type 2diabetes, 2018, pp.14, 1483~1496
44. Gehart, H., "MAPK signalling in cellular metabolism:stress or wellness?", EMBO Rep, 11, pp.834~840 (2010)
45. McKern, N. M., "Structure of the insulin receptor ectodomain reveals a folded-over conformation", Nature, 443, pp.218~221 (2006)
46. Croll, T. I., "Higher-resolution structure of the human insulin receptor ectodomain : multi-modal inclusion of the insert domain", Structure, 24, pp.469~476 (2016)
47. Williams, P. F., "Mapping of an NH2-terminal ligand binding site of the insulin receptor by alanine scanning mutagenesis", J. Biol. Chem, 270, pp.3012~3016 (1995)
48. Mynarcik, D. C., "Alanine-scanning mutagenesis of a C-terminal ligand binding domain of the insulin receptor alpha subunit", J. Biol. Chem, 271, pp.2439~2442 (1996)
49. Whittaker, J., "Characterization of the functional insulin binding epitopes of the full-length insulin receptor", J. Biol. Chem, 280, pp.20932~20936 (2005)
50. Kiselyov, V. V., "Harmonic oscillator model of the insulin and IGF1 receptors’ allosteric binding and activation", Mol. Syst. Biol, 5, pp.243~ (2009)
51. Schaffer, L., "A model for insulin binding to the insulin receptor", Eur. J. Biochem, 221, pp.1127~1132 (1994)
52. Xiong, X., "A structurally minimized yet fully active insulin based on conesnail venom insulin principles", Nat. Struct. Mol. Biol, 27, pp.615~624 (2020)
53. Kristensen, C., "Alanine scanning mutagenesis of insulin", J. Biol. Chem, 272, pp.12978~12983 (1997)
54. Li, J., "Structural basis of the activation of type 1 insulinlike growth factor receptor", Nat. Commun, 10, pp.4567~ (2019)
55. Blyth, A., "Determinants of IGF-II influencing stability, receptor binding and activation", Sci. Rep, 12, pp.4695~ (2022)
56. Yunn, N. -O., "A hotspot for enhancing insulin receptor activation revealed by a conformation-specific allosteric aptamer", Nucleic Acids Res, 49, pp.700~712 (2021)
57. Lawrence, C. F., "Insulin mimetic peptide disrupts the primary binding site of the insulin receptor", J. Biol. Chem, 291, pp.15473~15481 (2016)
58. Gutmann, T., "Visualization of ligandinduced transmembrane signaling in the full-length human insulin receptor", J. Cell Biol, 217, pp.1643~1649 (2018)
59. de Meyts, P., "Insulin interactions with its receptors : experimental evidence for negative cooperativity", Biochem. Biophys. Res. Commun, 55, pp.154~161 (1973)
60. DeMeyts, P., "Site-site interactions among insulin receptors. Characterization of the negative cooperativity", J. Biol. Chem, 251, pp.1877~1888 (1976)
61. Böni-Schnetzler, M., "The insulin receptor. Structural basis for high affinity ligand binding", J. Biol. Chem, 262, pp.8395~8401 (1987)
62. Sweet, L. J., "Isolation of functional alpha beta heterodimers from the purified human placental alpha 2 beta 2 heterotetrameric insulin receptor complex. A structural basis for insulin binding heterogeneity", J. Biol. Chem, 262, pp.6939~6942 (1987)
63. De Meyts, P., "The structural basis of insulin and insulin-like growth factor-I receptor binding and negative co-operativity, and its relevance to mitogenic versus metabolic signalling", Diabetologia, 37, pp.S135~S148 (1994)
64. Whittaker, L., "High-affinity insulin binding : insulin interacts with two receptor ligand binding sites", Biochemistry, 47, pp.12900~12909 (2008)
65. Daly, M. E., "Acute effects on insulin sensitivity and diurnal metabolic profiles of a high-sucrose compared with a high-starch diet", Am. J. Clin. Nutr, 67, pp.1186~1196 (1998)
66. Song, S. H., "Direct measurement of pulsatile insulin secretion from the portal vein in human subjects", J. Clin. Endocrinol. Metab, 85, pp.4491~4499 (2000)
67. Pørksen, N., "Pulsatile insulin secretion accounts for 70% of total insulin secretion during fasting", Am. J. Physiol, 269, pp.E478~E488 (1995)
68. Air, E. L., "Small molecule insulin mimetics reduce food intake and body weight and prevent development of obesity", Nat. Med, 8, pp.179~183 (2002)
69. Li, M., "Small molecule insulin receptor activators potentiate insulin action in insulin-resistant cells", Diabetes, 50, pp.2323~2328 (2001)
70. Zhang, B., "Discovery of a small molecule insulin mimetic with antidiabetic activity in mice", Science, 284, pp.974~977 (1999)
71. Schaffer, L., "Assembly of high-affinity insulin receptor agonists and antagonists from peptide building blocks", Proc. Natl Acad. Sci. USA, 100, pp.4435~4439 (2003)
72. Pillutla, R. C., "Peptides identify the critical hotspots involved in the biological activation of the insulin receptor", J. Biol. Chem, 277, pp.22590~22594 (2002)
73. Smith, J. S., "Biased signalling : from simple switches to allosteric microprocessors", Nat. Rev. Drug Discov, 17, pp.243~260 (2018)
74. Yunn, N. O., "Mechanistic understanding of insulin receptor modulation : Implications for the development of anti-diabetic drugs", Pharm. Ther, 185, pp.86~98 (2018)
75. Trenker, R., "Receptor tyrosine kinase activation : From the ligand perspective", Curr. Opin. Cell Biol, 63, pp.174~185 (2020)
76. Karl, K., "Ligand bias in receptor tyrosine kinase signaling", J. Biol. Chem, 295, pp.18494~18507 (2020)
77. Du, Z., "Mechanisms of receptor tyrosine kinase activation in cancer", Mol. Cancer, 17, pp.58~ (2018)
78. Hubbard, S. R., "Juxtamembrane autoinhibition in receptor tyrosine kinases", Nat. Rev. Mol. Cell Biol, 5, pp.464~471 (2004)
79. He, W., "Distinct modes of interaction of SHC and insulin receptor substrate-1 with the insulin receptor NPEY region via non-SH2domains", J. Biol. Chem, 270, pp.23258~23262 (1995)
80. Biener, Y., "Annexin II is a novel player in insulin signal transduction. Possible association between annexin II phosphorylation and insulin receptor internalization", J. Biol. Chem, 271, pp.29489~29496 (1996)
81. Ceresa, B. P., "Inhibition of clathrinmediated endocytosis selectively attenuates specific insulin receptor signal transduction pathways", Mol. Cell Biol, 18, pp.3862~3870 (1998)
82. Hamer, I., "An arginine to cysteine(252)mutation in insulin receptors from a patient with severe insulin resistance inhibits receptor internalisation but preserves signalling events", Diabetologia, 45, pp.657~667 (2002)
83. Backer, J. M., "Receptor-mediated internalization of insulin requires a 12-amino acid sequence in the juxtamembrane region of the insulin receptor beta-subunit", J. Biol. Chem, 265, pp.16450~16454 (1990)
84. Backer, J. M., "Insulin receptors internalize by a rapid, saturable pathway requiring receptor autophosphorylation and an intact juxtamembrane region", J. Cell Biol, 115, pp.1535~1545 (1991)
85. Kenakin, T., "Biased receptor signaling in drug discovery", Pharm. Rev, 71, pp.267~315 (2019)
86. Kelly, E., "Biased agonism : lessons from studies of opioid receptor agonists", Annu. Rev. Pharmacol. Toxicol, 63, pp.491~515 (2023)
87. Zaykov, A. N., "Pursuit of a perfect insulin", Nat. Rev. Drug Discov, 15, pp.425~439 (2016)
88. Janssen, J. A, "Insulin analogs and cancer: a note of caution", Front. Endocrinol, 5, pp.79~ (2014)
89. Sciacca, L., "Insulin analogs and cancer", Front. Endocrinol, 3, pp.21~ (2012)
90. Belfiore, A., "Insulin receptor and cancer", Endocr. Relat. Cancer, 18, pp.R125~R147 (2011)
91. Gerstein, H. C., "Long-term effects of intensive glucose lowering on cardiovascular outcomes", N. Engl. J. Med, 364, pp.818~828 (2011)
92. Holman, R. R., "10-year follow-up of intensive glucose control in type 2 diabetes", N. Engl. J. Med, 359, pp.1577~1589 (2008)
93. Steinberg, H. O., "Insulinmediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release", J. Clin. Invest, 94, pp.1172~1179 (1994)
94. Zeng, G., "Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells", Circulation, 101, pp.1539~1545 (2000)
95. Dzau, V. J., "Vascular proliferation and atherosclerosis : new perspectives and therapeutic strategies", Nat. Med, 8, pp.1249~1256 (2002)
96. Cersosimo, E., "Potential role of insulin signaling on vascular smooth muscle cell migration, proliferation, and inflammation pathways", Am. J. Physiol. Cell Physiol, 302, pp.C652~C657 (2012)
97. Coletta, D. K., "Effect of acute physiological hyperinsulinemia on gene expression in human skeletal muscle in vivo", Am. J. Physiol. Endocrinol. Metab, 294, pp.E910~E917 (2008)
98. Hsueh, W. A., "Insulin signaling in the arterial wall", Am. J. Cardiol, 84, pp.21j~24j (1999)
99. Scully, T., "Obesity, type 2 diabetes, and cancer risk", Front. Oncol, 10, pp.615375~ (2020)
100. Ish-Shalom, D., "Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor", Diabetologia, 40, pp.S25~S31 (1997)
101. Chen, Y., "Association of high insulin receptor expression with poor prognosis in patients with breast cancer", Gland Surg, 12, pp.252~262 (2023)
102. Sanaki, Y., "Hyperinsulinemia drives epithelial tumorigenesis by abrogating cell competition", Dev. Cell, 53, pp.379~389 (2020)
103. Weingarten, G., "Insulin receptor plays a central role in skin carcinogenesis by regulating cytoskeleton assembly", Faseb J., 33, pp.2241~2251 (2018)
104. Kanter, J. E., "A novel strategy to prevent advanced atherosclerosis and lower blood glucose in a mouse model of metabolic syndrome", Diabetes, 67, pp.946~959 (2018)
105. Lemmon, M. A., "The EGFR family : not so prototypical receptor tyrosine kinases", Cold Spring Harb. Perspect. Biol, 6, pp.a020768~ (2014)

관련 논문AI추천